In glucocorticoid-dependent polymyalgia rheumatica, tocilizumab improved a composite clinical outcome at 24 wk.
Publication
, Journal Article
Pisetsky, DS
Published in: Annals of internal medicine
January 2023
Devauchelle-Pensec V, Carvajal-Alegria G, Dernis E, et al. Effect of tocilizumab on disease activity in patients with active polymyalgia rheumatica receiving glucocorticoid therapy: a randomized clinical trial. JAMA. 2022;328:1053-62. 36125471.
Duke Scholars
Published In
Annals of internal medicine
DOI
EISSN
1539-3704
ISSN
0003-4819
Publication Date
January 2023
Volume
176
Issue
1
Start / End Page
JC5
Related Subject Headings
- Randomized Controlled Trials as Topic
- Polymyalgia Rheumatica
- Humans
- Glucocorticoids
- Giant Cell Arteritis
- General & Internal Medicine
- Antibodies, Monoclonal, Humanized
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Pisetsky, D. S. (2023). In glucocorticoid-dependent polymyalgia rheumatica, tocilizumab improved a composite clinical outcome at 24 wk. Annals of Internal Medicine, 176(1), JC5. https://doi.org/10.7326/j22-0107
Pisetsky, David S. “In glucocorticoid-dependent polymyalgia rheumatica, tocilizumab improved a composite clinical outcome at 24 wk.” Annals of Internal Medicine 176, no. 1 (January 2023): JC5. https://doi.org/10.7326/j22-0107.
Pisetsky DS. In glucocorticoid-dependent polymyalgia rheumatica, tocilizumab improved a composite clinical outcome at 24 wk. Annals of internal medicine. 2023 Jan;176(1):JC5.
Pisetsky, David S. “In glucocorticoid-dependent polymyalgia rheumatica, tocilizumab improved a composite clinical outcome at 24 wk.” Annals of Internal Medicine, vol. 176, no. 1, Jan. 2023, p. JC5. Epmc, doi:10.7326/j22-0107.
Pisetsky DS. In glucocorticoid-dependent polymyalgia rheumatica, tocilizumab improved a composite clinical outcome at 24 wk. Annals of internal medicine. 2023 Jan;176(1):JC5.
Published In
Annals of internal medicine
DOI
EISSN
1539-3704
ISSN
0003-4819
Publication Date
January 2023
Volume
176
Issue
1
Start / End Page
JC5
Related Subject Headings
- Randomized Controlled Trials as Topic
- Polymyalgia Rheumatica
- Humans
- Glucocorticoids
- Giant Cell Arteritis
- General & Internal Medicine
- Antibodies, Monoclonal, Humanized
- 3202 Clinical sciences
- 11 Medical and Health Sciences